Latanoprostene bunod ophthalmic solution (Vyzulta) for the reduction of 
intraocular pressure; letermovir (Prevymis) for prophylaxis of cytomegalovirus 
infection and disease after stem cell transplant; benralizumab (Fasenra) for the 
add-on maintenance treatment of severe asthma of an eosinophilic phenotype.